Showing results (1-10 of 446) with videos related to
Sort By:
Pageof 45
Digestive Diseases and Sciences|November 25, 2003
Rofecoxib reduces polyp recurrence in familial polyposisA Hallak, L Alon-Baron, R Shamir, et al.Israel Journal of Medical Sciences|June 1, 1995
Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatmentZ Halpern, N Arber, A Hallak, et al.Digestive Diseases and Sciences|October 30, 2001
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trialI Dotan, A Hallak, N Arber, et al.Digestive Diseases and Sciences|November 1, 1995
Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infectionN Arber, M Moshkowitz, F Konikoff, et al.Digestive Diseases and Sciences|December 1, 1994
Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseasesN Arber, F M Konikoff, M Moshkowitz, et al.Journal of the American Geriatrics Society|June 12, 1999
The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsiaM Moshkowitz, S Brill, F M Konikoff, et al.The Israel Medical Association Journal : IMAJ|May 10, 2001
Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patientsM Moshkowitz, S Brill, F M Konikoff, et al.Pediatrics|July 4, 1998
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescentsM Moshkowitz, S Reif, S Brill, et al.Harefuah|February 1, 1994
[Antimicrobial sensitivity and treatment of Helicobacter pylori infections]M Moshkowitz, M Santo, A Hallak, et al.Gastroenterology|June 2, 2000
Activation of c-K-ras mutations in human gastrointestinal tumorsN Arber, I Shapira, J Ratan, et al.Pageof 45